{
  "resourceType": "CodeSystem",
  "id": "napkon-pediatrics-module",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This code system https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/napkon-pediatrics-module defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">000001<a name=\"napkon-pediatrics-module-000001\"> </a></td><td>Sphingosine analogue (substance)</td></tr><tr><td style=\"white-space:nowrap\">000002<a name=\"napkon-pediatrics-module-000002\"> </a></td><td>Substance with interleukin 2 receptor antagonist mechanism of action (substance)</td></tr><tr><td style=\"white-space:nowrap\">000003<a name=\"napkon-pediatrics-module-000003\"> </a></td><td>Substance with interleukin 17 receptor antagonist mechanism of action (substance)</td></tr><tr><td style=\"white-space:nowrap\">000004<a name=\"napkon-pediatrics-module-000004\"> </a></td><td>Anti-CD20 antibody (substance)</td></tr><tr><td style=\"white-space:nowrap\">000005<a name=\"napkon-pediatrics-module-000005\"> </a></td><td>Anti-CD52 antibody (substance)</td></tr><tr><td style=\"white-space:nowrap\">000006<a name=\"napkon-pediatrics-module-000006\"> </a></td><td>Anti-CD3 antibody (substance)</td></tr><tr><td style=\"white-space:nowrap\">000007<a name=\"napkon-pediatrics-module-000007\"> </a></td><td>Anti-CD3/CD19 antibody (substance)</td></tr><tr><td style=\"white-space:nowrap\">000008<a name=\"napkon-pediatrics-module-000008\"> </a></td><td>Substance with Integrin inhibitor mechanism of action (substance)</td></tr><tr><td style=\"white-space:nowrap\">000009<a name=\"napkon-pediatrics-module-000009\"> </a></td><td>Substance with B cell activating factor inhibitor mechanism of action (substance)</td></tr></table></div>"
  },
  "url": "https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/napkon-pediatrics-module",
  "version": "0.1.0",
  "name": "NapkonPediatricsModule",
  "title": "NapkonPediatricsModule",
  "status": "active",
  "date": "2021-10-12T09:47:10+00:00",
  "publisher": "BIH @ Charité",
  "contact": [
    {
      "name": "BIH @ Charité",
      "telecom": [
        {
          "system": "url",
          "value": "https://www.netzwerk-universitaetsmedizin.de"
        }
      ]
    }
  ],
  "description": "NAPKON Pediatrics Module Code System - Collection of pediatrics module-specific codes that are missing from common terminologies such as SNOMED CT",
  "content": "complete",
  "count": 9,
  "concept": [
    {
      "code": "000001",
      "display": "Sphingosine analogue (substance)"
    },
    {
      "code": "000002",
      "display": "Substance with interleukin 2 receptor antagonist mechanism of action (substance)"
    },
    {
      "code": "000003",
      "display": "Substance with interleukin 17 receptor antagonist mechanism of action (substance)"
    },
    {
      "code": "000004",
      "display": "Anti-CD20 antibody (substance)"
    },
    {
      "code": "000005",
      "display": "Anti-CD52 antibody (substance)"
    },
    {
      "code": "000006",
      "display": "Anti-CD3 antibody (substance)"
    },
    {
      "code": "000007",
      "display": "Anti-CD3/CD19 antibody (substance)"
    },
    {
      "code": "000008",
      "display": "Substance with Integrin inhibitor mechanism of action (substance)"
    },
    {
      "code": "000009",
      "display": "Substance with B cell activating factor inhibitor mechanism of action (substance)"
    }
  ]
}